Trademark: 88829952
Word

Status
Registered
Status Code
700
Status Date
Tuesday, April 26, 2022
Serial Number
88829952
Registration Number
6713848
Registration Date
Tuesday, April 26, 2022
Mark Type
2000
Filing Date
Wednesday, March 11, 2020
Published for Opposition
Tuesday, July 14, 2020

Trademark Owner History
Sarepta Therapeutics, Inc. - Original Registrant

Classifications
44 medical information services, namely, providing information relating to rare diseases, medicines, health conditions, and treatment options; Provision of health care services, namely, providing information to doctors and patients regarding rare diseases, medicines, health conditions and treatment options; providing a website featuring medical information in the field of rare and infectious diseases; providing a website featuring information in the field of the diagnosis and treatment of muscular dystrophies, neuromuscular diseases, and central nervous system diseases; providing a website featuring information in the field of medicine via electronic and optical communications networks
42 medical and scientific research services, namely, medical research; medical and scientific research services all in the field of rare and infectious diseases; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies
The mark consists of an abstract representation of the DNA double helix structure in white and gold. The color black shown in the mark is background and is not part of the mark.
The color(s) white and gold is/are claimed as a feature of the mark.

Trademark Events
Apr 26, 2022
Registered-Principal Register
Mar 24, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 23, 2022
Allowed Principal Register - Sou Accepted
Mar 19, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 18, 2022
Statement Of Use Processing Complete
Mar 3, 2022
Use Amendment Filed
Mar 18, 2022
Sou Extension 3 Granted
Mar 3, 2022
Sou Extension 3 Filed
Mar 14, 2022
Case Assigned To Intent To Use Paralegal
Mar 3, 2022
Teas Extension Received
Mar 3, 2022
Teas Statement Of Use Received
Sep 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 8, 2021
Sou Extension 2 Granted
Sep 8, 2021
Sou Extension 2 Filed
Sep 8, 2021
Teas Extension Received
Mar 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 8, 2021
Sou Extension 1 Granted
Mar 8, 2021
Sou Extension 1 Filed
Mar 8, 2021
Teas Extension Received
Sep 8, 2020
Noa E-Mailed - Sou Required From Applicant
Jul 14, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 14, 2020
Published For Opposition
Jun 24, 2020
Notification Of Notice Of Publication E-Mailed
Jun 9, 2020
Approved For Pub - Principal Register
Jun 9, 2020
Examiner's Amendment Entered
Jun 9, 2020
Notification Of Examiners Amendment E-Mailed
Jun 9, 2020
Examiners Amendment E-Mailed
Jun 9, 2020
Examiners Amendment -Written
Jun 3, 2020
Notification Of Non-Final Action E-Mailed
Jun 3, 2020
Non-Final Action E-Mailed
Jun 3, 2020
Non-Final Action Written
Jun 3, 2020
Assigned To Examiner
Mar 18, 2020
Notice Of Design Search Code E-Mailed
Mar 17, 2020
New Application Office Supplied Data Entered In Tram
Mar 14, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24